Hospital Italiano de La Plata | Clinical Research Department
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to evaluate the safety and efficacy of deucravacitinib versus placebo for the treatment of participants with active PsA who are naïve to biologic disease modifying antirheumatic drugs or had previously received TNFα inhibitor treatment.The long term extension period will provide additional long-term safety and efficacy information.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Other protocol-defined inclusion/exclusion criteria apply
Primary purpose
Allocation
Interventional model
Masking
700 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
BMS Study Connect Contact Center www.BMSStudyConnect.com; First line of email MUST contain NCT # and site #.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal